Souhaitez-vous accéder aux communiqués récents ?

PORTLAND, Ore., Sept. 23, 2025 (GLOBE NEWSWIRE) -- When it comes to GLP-1 weight loss medications, including Ozempic®, Zepbound® and Wegovy®, having access is only part of the equation. Patients need...

PORTLAND, Ore., Sept. 23, 2025 (GLOBE NEWSWIRE) -- When it comes to GLP-1 weight loss medications, including Ozempic®, Zepbound® and Wegovy®, having access is only part of the equation. Patients need...

Denver, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Actual Veggies, a CPG leader known for its chef-crafted veggie burgers and vegetable-forward products, has been named to the 2025 Inc. 5000 list of...

Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "Europe Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034" has been added to ResearchAndMarkets.com's offering. The...

Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "GLP-1 Agonists Drug Pipeline Analysis Report 2025" drug pipelines has been added to ResearchAndMarkets.com's offering.The GLP-1 Agonists Drug Pipeline...

Dublin, July 10, 2025 (GLOBE NEWSWIRE) -- The "United States Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's...

Dublin, July 02, 2025 (GLOBE NEWSWIRE) -- The "Semaglutide Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's...

NorthStrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases

Sagapixel reports “GLP-1” has overtaken “Ozempic” in search volume, signaling a major shift in patient awareness and provider marketing and SEO strategy.

NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Re